CoChat

Use of p62/SQSTM1 antibodies for neuropathological diagnosis

Kuusisto, E., Kauppinen, T., Alafuzoff, I. · 2008 · Neuropathology and Applied Neurobiology
Cited by 113

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The demonstration of proteinaceous inclusions in the brain is the key step in the pathological diagnosis of degenerative dementias. The diversity of these diseases has necessitated the use of a panel of (immuno)stains to visualize all suspect pathologies, elevating diagnostic costs. Immunodetection of p62 (sequestosome 1), an abundant constituent in diverse pathological inclusions, holds the potential for a broad‐specificity, high‐contrast inclusion label. In the brain, pathological p62‐positive aggregates comprise both cytoplasmic and nuclear types in neurones and glia, with abnormal tau, alpha‐synuclein, TAR DNA‐binding protein 43 or polyglutamine proteins as primary components. We therefore set out to evaluate the performance of p62 antibodies for diagnostic immunohistochemistry. We optimized the application conditions and compared the staining profiles of eight commercial p62 antibodies with each other and with reference immunostains, using 2‐mm tissue multiarrays representing the major tauo‐ and synucleinopathies and frontotemporal lobar degeneration with ubiquitin‐positive inclusions (FTLD‐U). The lesions were best visualized using monoclonal antibodies, displaying most types of hallmark inclusions with excellent contrast. Expanding the list of p62‐containing aggregates, we demonstrated p62 in tufted astrocytes, coiled bodies, astrocytic plaques, and variform neocortical inclusions and pathological processes in FTLD‐U. Polyclonal antibodies exhibited lower sensitivities with variable background levels. We also noted more subtle p62‐immunoreactive features lacking overt disease associations. Emphasizing the importance of proper antibody and epitope unmasking methods for maximum sensitivity, we recommend p62 immunodetection as a screening stain for diagnostic practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2007.00884.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 113

Metadata

Authors
Kuusisto, E., Kauppinen, T., & Alafuzoff, I.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2007-10-31
Volume
34
Issue
2
Pages
169-180
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W1982916090
Cited by
113
References
6
FWCI
4.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of p62/SQSTM1 antibodies for neuropathological diagnosis. https://app.cochat.ai/papers/10.1111/j.1365-2990.2007.00884.x
The paper
Kuusisto, E., Kauppinen, T., & Alafuzoff, I. (2008). Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.2007.00884.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.